Hillan Kenneth J.

Chief Therapeutics Officer at ME; Officer, Director at Achaogen Inc; Director at Relypsa Inc

Sold, on record
$296k
Dollars the filings state
Form 4 sales
9
Latest Aug 24, 2022
Form 144 notices
0
Proposed sales
Companies
3
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Relypsa IncUnusual
    Jun 7 2016

    Sold 1,013 shares at $19.31 ($20k)

    Hillan Kenneth J., Director

    Sold 45% of holdings ($43k position)1,237 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Achaogen IncPlan not stated
    Jan 26 +233 days

    Sold 1,431 shares at $16.78 ($24k)

    Hillan Kenneth J., Chief Executive Officer

    Sold 2.2% of holdings ($1.1M position)63,197 shares leftFiling

  3. 3 Form 4 sale Achaogen IncPlan not stated
    Feb 21 +26 days

    Sold 1,696 shares at $22.76 ($39k)

    Hillan Kenneth J., Chief Executive Officer

    Sold 2.7% of holdings ($1.4M position)61,501 shares leftFiling

  4. 4 Form 4 sale Achaogen IncPlan not stated
    Mar 14 +21 days

    Sold 3,079 shares at $26.58 ($82k)

    Hillan Kenneth J., Chief Executive Officer

    Sold 3% of holdings ($2.7M position)98,422 shares left1.8x usual sizeFiling

  5. 5 Form 4 sale Achaogen IncPlan not stated
    Feb 21 +344 days

    Sold 4,606 shares at $10.67 ($49k)

    Hillan Kenneth J., Officer, Director

    Sold 4.5% of holdings ($1.1M position)97,886 shares left1.9x usual sizeFiling

  6. 6 Form 4 sale Achaogen IncPlan not stated
    Mar 13 +20 days

    Sold 2,735 shares at $11.74 ($32k)

    Hillan Kenneth J., Officer, Director

    Sold 2.8% of holdings ($1.1M position)95,151 shares left0.9x usual sizeFiling

  7. 7 Form 4 sale Achaogen IncPlan not stated
    Jun 26 +105 days

    Sold 744 shares at $9.59 ($7k)

    Hillan Kenneth J., Officer, Director

    Sold 0.6% of holdings ($1.1M position)115,401 shares left0.3x usual sizeFiling

  8. 8 Form 4 sale MEPlan not stated
    Aug 24 +1520 days

    Sold 8,753 shares at $3.64 ($32k)

    Hillan Kenneth J., Chief Therapeutics Officer

    Sold 4.3% of holdings ($746k position)196,083 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (9)

Form 144 notices and Form 4 sales by Hillan Kenneth J.
Source
Aug 24, 2022MEChief Therapeutics OfficerForm 4 sale8,753$32k4.3%Plan not statedSEC
Jun 26, 2018Achaogen IncOfficer, DirectorForm 4 sale744$7k0.6%Plan not statedSEC
Mar 13, 2018Achaogen IncOfficer, DirectorForm 4 sale2,735$32k2.8%Plan not statedSEC
Feb 21, 2018Achaogen IncOfficer, DirectorForm 4 sale4,606$49k4.5%Plan not statedSEC
Mar 14, 2017Achaogen IncChief Executive OfficerForm 4 sale3,079$82k3.0%Plan not statedSEC
Feb 21, 2017Achaogen IncChief Executive OfficerForm 4 sale1,696$39k2.7%Plan not statedSEC
Jan 26, 2017Achaogen IncChief Executive OfficerForm 4 sale1,431$24k2.2%Plan not statedSEC
Jun 7, 2016Relypsa IncDirectorForm 4 sale1,013$20k45.0%UnusualSEC
Mar 17, 2016Achaogen IncChief Executive OfficerForm 4 sale3,572$12k5.5%Plan not statedSEC